Sign in

CIK 0001521036

  • Large accelerated filer

Lantheus Holdings, Inc.

Sign in to watch
Ticker
LNTH
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
352318913
Phone
+1 978-671-8001
Business address
201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
Former names
Lantheus MI Holdings, Inc.
  1. 4 Open-market sale CFO and Treasurer sold 5,000 shares at $59.00 ($295,000)
  2. 4 Open-market sale Chief Accounting Officer sold 386 shares at $59.00 ($22,774)
  3. 4 Open-market sale Niedzwiecki Daniel sold 3,000 shares at $59.73 ($179,190)
  4. 4 Open-market sale President & CEO sold 13,150 shares at an average $57.21 ($752,365)
  5. 4 Open-market sale Chief Business Officer sold 5,860 shares at an average $72.50 ($424,874)
  6. 4 Open-market sale CFO and Treasurer sold 4,828 shares at $73.41 ($354,443)
  7. 4 Open-market sale Chief Accounting Officer sold 386 shares at $70.50 ($27,213)
  8. 4 Open-market sale Chief Accounting Officer sold 386 shares at $85.83 ($33,130)
  9. 4 Open-market sale Director sold 41,812 shares at an average $84.24 ($3,522,293)
  10. 4 Open-market sale Director sold 4,300 shares at $78.50 ($337,550)
  11. 4 Open-market sale Director sold 1,693 shares at $78.50 ($132,901)
  12. 4 Open-market sale Chief Operating Officer sold 1,500 shares at $83.39 ($125,085)
  13. 4 Open-market sale Chief Accounting Officer sold 386 shares at $82.82 ($31,969)
  14. 4 Open-market sale CFO and Treasurer sold 5,000 shares at $82.82 ($414,100)
  15. 4 Open-market sale Niedzwiecki Daniel sold 3,000 shares at $82.66 ($247,980)
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 11 of 30 · 598 filings